Drug Type Small molecule drug |
Synonyms Clonixin (USAN/INN), L-104, R-173 |
Target |
Mechanism ADRA2B agonists(Alpha-2b adrenergic receptor agonists), α2A-AR agonists(Alpha-2a adrenergic receptor agonists), α2C-AR agonists(Alpha-2c adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC13H11ClN2O2 |
InChIKeyCLOMYZFHNHFSIQ-UHFFFAOYSA-N |
CAS Registry17737-65-4 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pain | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Low Back Pain | Phase 3 | BR | 01 May 2012 |